I think the self-imposed stop of the brazil trial was a very big mistake by our new management.
It seems that the doctors and regulators in brazil did not have any major concerns due to those two deceased patients, since cardiac arrest seems to be not so unusual with COVID patients on the ICU (25% of COVID ICU patients die). Secondly it is still unknown if the cardiac arrests have happened in LL or placebo arm.
So I believe the self- imposed stop was also reported to US FDA and US FDA made a big issue out of nothing and as a consequence all LL HIV patients must now move to the toxic Gilead cocktail. The used LL for up to seven years without any problems and probably with a high quality of life with LL.
Now those longtime LL HIV patients will probably have a significant reduction of life quality and one or the other will have problems with the toxic Gilead cocktail. How many LL HIV patients will die due to this overreaction of US FDA? For some this is a death sentence ... but I guess if FDA does not care about 1M COVID deaths then they do not care for those few poor bastards anyways.